GELS
Gelteq Limited
0.9611
+0.0011+0.12%
Dec 16, 4:00:02 PM EST

Upcoming Earnings 

Report date
≈ -/-

Earnings Call Transcripts

This Quarter (Q4 '25)

No earnings call transcript available yet

Last Quarter (Q3 '25)

No earnings call transcript available

Key Stats

Market Cap
10.29M
P/E (TTM)
-
Basic EPS (TTM)
-0.48
Dividend Yield
0%

About 

Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.

CEO
Mr. Nathan Jacob Givoni
IPO
10/29/2024
Employees
7
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic